Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Roivant Sciences (ROIV) Operating Income (2020 - 2025)

Roivant Sciences' Operating Income history spans 6 years, with the latest figure at -$339.2 million for Q4 2025.

  • For Q4 2025, Operating Income fell 23.61% year-over-year to -$339.2 million; the TTM value through Dec 2025 reached -$1.2 billion, down 127.32%, while the annual FY2025 figure was -$1.0 billion, 122.31% down from the prior year.
  • Operating Income reached -$339.2 million in Q4 2025 per ROIV's latest filing, down from -$306.2 million in the prior quarter.
  • In the past five years, Operating Income ranged from a high of $5.1 billion in Q4 2023 to a low of -$684.4 million in Q3 2021.
  • Average Operating Income over 5 years is $64.2 million, with a median of -$280.8 million recorded in 2022.
  • Peak YoY movement for Operating Income: crashed 337.22% in 2021, then skyrocketed 1456.19% in 2023.
  • A 5-year view of Operating Income shows it stood at -$246.0 million in 2021, then tumbled by 53.68% to -$378.1 million in 2022, then surged by 1456.19% to $5.1 billion in 2023, then tumbled by 105.35% to -$274.4 million in 2024, then dropped by 23.61% to -$339.2 million in 2025.
  • Per Business Quant, the three most recent readings for ROIV's Operating Income are -$339.2 million (Q4 2025), -$306.2 million (Q3 2025), and -$284.9 million (Q2 2025).